Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023) [0.03%]
葡萄牙呼吸道合胞病毒遗传学和流行病学特征分析：住院病例与社区病例对比研究（2021-2023）
Miguel Lança,Vânia Gaio,Ana Paula Rodrigues et al.
Miguel Lança et al.
Background: Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infection (ARI) in young children, but its genetic diversity requires ongoing surveillance. ...
Comparative Study
Influenza and other respiratory viruses. 2025 Oct;19(10):e70147. DOI:10.1111/irv.70147 2025
Clinical and Socioeconomic Burden of RSV Infections Among Older Adults in Primary Care: An International Prospective Cohort Study [0.03%]
国际老年患者初级保健机构RSV感染临床和社会经济负担的前瞻性队列研究
Sarah F Hak,Joanne G Wildenbeest,Sara Bracaloni et al.
Sarah F Hak et al.
Introduction: Respiratory syncytial virus (RSV) is increasingly recognized as an important cause of acute respiratory infections (ARI) in older adults. However, primary care data on RSV infections are scarce. ...
Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure-Activity Relationship [0.03%]
抗冠状病毒异喹啉生物碱：揭示其构效关系的秘密
Marcela Safratova,Yu-Li Chen,Anna Hostalkova et al.
Marcela Safratova et al.
Background: Natural alkaloids are a structurally diverse class of bioactive compounds with significant therapeutic potential. This study aimed to evaluate the in vitro antiviral activity of various natural alkaloids again...
Francisco M Guerra Jr,Emily M Edgar,Judith U Oguzie et al.
Francisco M Guerra Jr et al.
Cost-Effectiveness Analysis of Nirsevimab for Respiratory Syncytial Virus Disease Prevention in Newborns of Hong Kong [0.03%]
香港新生儿防治呼吸道合胞病毒疾病的奈西利马布成本效益分析
Yingcheng Wang,Mingjun Rui,Qiran Wei et al.
Yingcheng Wang et al.
Background: Nirsevimab, a long-acting monoclonal antibody, was shown to prevent respiratory syncytial virus (RSV) infections in newborns. We evaluated the cost-effectiveness of nirsevimab strategies for newborns from the ...
Absences, Symptoms and Respiratory Viruses in a Swiss School: Longitudinal Study With Serial Saliva Sampling [0.03%]
瑞士一所学校中儿童缺课、症状与呼吸道病毒的纵向研究：连续采集唾液标本的研究
Nicolas Banholzer,David Kronthaler,Pascal Bittel et al.
Nicolas Banholzer et al.
Background: Viral respiratory infections contribute to sick days in school children. We monitored respiratory infections, absences, and symptoms in a Swiss school. ...
First Detection of Boosepivirus B1 in a Sick Yearling's Nasal Swab, Mexico [0.03%]
墨西哥病犊鼻拭子中首次检测到Boosepi病毒B1型
Judith U Oguzie,Gustavo Hernandez-Vidal,Gustavo Moreno-Degollado et al.
Judith U Oguzie et al.
Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 2020 [0.03%]
西班牙在2020年进行重大呼吸道病毒监测变更后的疫情和强度阈值的建立
Ana María Puerto,José Eugenio Lozano,Marcos Lozano et al.
Ana María Puerto et al.
Objectives: We estimated acute respiratory infections (ARIs) and influenza-like illness (ILI) thresholds for SiVIRA, a new integrated surveillance system set up in Spain in 2020. ...
Prevalence of Resistance-Associated Mutations in RSV F Protein Against Monoclonal Antibodies Prior to Widespread Implementation: Findings From a Prospective German Pediatric Cohort [0.03%]
德国儿科前瞻性队列中广泛实施前RSV F蛋白单克隆抗体抗性相关突变的流行率
Martin Wetzke,Duyen Bao Le,Inga Tometten et al.
Martin Wetzke et al.
Background: The emergence of resistance-associated substitutions in RSV against novel monoclonal antibodies is a concern given widespread prophylactic use. ...